Aerie Pharmaceuticals announces debt conversion and new credit facility with Deerfield

|About: Aerie Pharmaceuticals, ... (AERI)|By:, SA News Editor

Aerie Pharmaceuticals (AERI) announces the conversion of $125M of senior secured convertible notes held by affiliates of Deerfield Management Company L.P. into 5.04M and 0.33M common shares, thereby increasing the number of outstanding shares to 45.21M .

The company also entered into a $100M senior secured delayed draw term loan facility with affiliates of Deerfield, maturing on July 23, 2024.

Net proceeds from the credit facility, if drawn, will be used for working capital and general corporate purposes.

Subscribe for full text news in your inbox